Drug Development Biotechnology Acquisitions Drug Pricing Manufacturing Vaccine Development Drug Manufacturing Corporate Governance Mergers and Acquisitions Companies
The move positions Merck to integrate the fast-growing Ohtuvayre COPD therapy into its pipeline to help offset looming Keytruda revenue losses.